Phase Ib trial of brostallicin in combination with bevacizumab or irinotecan in patients with advanced solid tumours
Phase of Trial: Phase I
Latest Information Update: 01 Dec 2008
At a glance
- Drugs Brostallicin (Primary) ; Bevacizumab; Irinotecan
- Indications Solid tumours
- Focus Adverse reactions; Pharmacogenomic
- 01 Nov 2007 New trial record.